About Enhancer
| Enhancer ID: | E_01_0300 |
| Species: | human |
| Position : | chr14:64081786-64083786   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Autoimmune diseases |
| Pubmed ID: | 30676242 |
| Enhancer experiment: | ChIP-seq |
| Enhancer experiment description: | They were also more likely to be in ARNT and ESR2 transcription factor binding sites |
About Target gene
| Target gene : | -- |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | They were also more likely to be in ARNT and ESR2 transcription factor binding sites |
About TF
| TF name : | ESR2 |
| TF experiment: | ChIP-seq |
| TF experiment description: | They were also more likely to be in ARNT and ESR2 transcription factor binding sites |
About Function
| Enhancer function : | They were also more likely to be in ARNT and ESR2 transcription factor binding sites |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
They were also more likely to be in ARNT and ESR2 transcription factor binding sites |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| ESR2 | Nuclear Receptor transcription pathway | reactome | 51 |
| ESR2 | Plasma membrane estrogen receptor signaling | pid | 42 |
| ESR2 | Validated nuclear estrogen receptor alpha network | pid | 65 |
| ESR2 | Validated nuclear estrogen receptor beta network | pid | 15 |
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene